Target Price | HKD9.88 |
Price | HKD9.66 |
Potential |
2.23%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Grand Pharmaceutical 2026 .
The average Grand Pharmaceutical target price is HKD9.88.
This is
2.23%
register free of charge
HKD10.15
5.07%
register free of charge
HKD9.60
0.62%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Grand Pharmaceutical to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Grand Pharmaceutical stock has an average upside potential 2026 of
2.23%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 11.64 | 12.42 |
10.59% | 6.69% | |
EBITDA Margin | 23.39% | 23.99% |
24.25% | 2.58% | |
Net Margin | 21.20% | 16.91% |
18.72% | 20.22% |
4 Analysts have issued a sales forecast Grand Pharmaceutical 2025 . The average Grand Pharmaceutical sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Grand Pharmaceutical 2025 . The average Grand Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.70 | 0.60 |
29.63% | 14.29% | |
P/E | 16.10 | |
EV/Sales | 2.94 |
1 Analysts have issued a Grand Pharmaceutical forecast for earnings per share. The average Grand Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Grand Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.